Munich Personal RePEc Archive
metadata only
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry
Since Comanor and Scherer (1969), researchers have been using patents as a proxy for new product development. In this paper, we reevaluate this relationship by using novel new data. We demonstrate that the relationship between patenting and new FDA-approved product introductions has diminished con
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- S211014 Discussion on Technical Standardization and Patents#195973
- Sequential analysis for post-marketing drug safety surveillance using routinely collected electronic healthcare data: a scoping review.#354638
- 21 CFR Part 99 — Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices#506729
- 21 CFR Part 203 — Prescription Drug Marketing#506793
- Liminal Innovation Practices: questioning three common assumptions in responsible innovation#753091
Record · ID 1276014
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive